Residency · Residency · Child Adolescent Psychiatry

First-Episode Psychosis in Adolescents: Assessment and Coordinated Specialty Care

Overview

First-episode psychosis (FEP) most commonly presents in late adolescence and early adulthood, with peak onset between ages 15 and 25. FEP is a psychiatric emergency requiring rapid assessment, a medical workup to exclude organic causes, and prompt initiation of treatment. Duration of untreated psychosis (DUP) is a critical prognostic factor, as longer DUP is consistently associated with worse outcomes across multiple domains. Coordinated specialty care (CSC) programs — including NAVIGATE, RAISE, and OnTrackNY — have demonstrated superior outcomes compared to treatment as usual. CSC integrates low-dose antipsychotic medication, individual therapy (CBT for psychosis), family psychoeducation, and supported employment or education. Early identification and intervention can significantly alter the trajectory of psychotic illness.

Initial Assessment

Clinical Evaluation

The clinical evaluation should include a detailed history of symptom onset, progression, and timeline. Positive symptoms must be assessed: hallucinations (their modality, content, and whether they are command in nature), delusions (their type and fixedness), disorganized speech, and disorganized or catatonic behavior. Negative symptoms require evaluation: flat affect, alogia, avolition, anhedonia, and social withdrawal. Cognitive assessment should address attention, working memory, and processing speed, which are often impaired at first episode. Functional assessment should cover academic or occupational functioning, social relationships, and self-care. Premorbid functioning — the patient's baseline prior to symptom onset — provides an important reference point. Risk assessment must address suicidality (which is elevated in FEP, with approximately 5-10% lifetime suicide rate in schizophrenia), violence risk, and self-neglect.

Duration of Untreated Psychosis (DUP)

DUP is defined as the time from onset of frank psychotic symptoms to initiation of adequate antipsychotic treatment. The mean DUP in the United States is approximately 74 weeks, based on RAISE study data — a remarkably long delay. Longer DUP is associated with poorer treatment response, more severe negative symptoms, greater cognitive impairment, worse social and occupational functioning, and higher relapse rates. Reducing DUP is a major public health goal, and early identification programs in schools and primary care settings are essential strategies for achieving it.

Medical Workup to Exclude Organic Causes

A thorough medical workup is essential for all FEP patients, and this is especially important in adolescents where medical etiologies are more common than in older adults. The basic workup should include CBC, CMP, thyroid function tests, and urinalysis. A urine drug screen is critical, as cannabis, stimulants, PCP, and hallucinogens are common causes of psychosis in adolescents. Brain MRI should be obtained to rule out space-occupying lesions, demyelinating disease, and structural abnormalities. EEG should be considered if seizures are suspected, since temporal lobe epilepsy can cause psychotic symptoms. Anti-NMDA receptor antibody testing should be considered, especially in females with rapid onset, seizures, movement abnormalities, or autonomic instability. HIV testing and syphilis screening (RPR/VDRL) should be obtained in at-risk adolescents. Ceruloplasmin and 24-hour urine copper should be checked if movement abnormalities are present, to evaluate for Wilson disease. Chromosomal microarray for 22q11.2 deletion syndrome should be ordered, especially if the developmental history is abnormal. Metabolic screening including homocysteine and urine organic acids should be considered if the presentation is atypical.

Substance-Induced Psychosis

Cannabis is the most common substance associated with psychosis in adolescents. High-potency THC products, synthetic cannabinoids, stimulants (methamphetamine and cocaine), hallucinogens (LSD and psilocybin), PCP, and ketamine can all produce psychotic symptoms. Substance-induced psychosis should resolve within days to weeks of abstinence; if symptoms persist, a primary psychotic disorder should be suspected. Cannabis use during adolescence increases the risk of developing schizophrenia 2-6 fold, with risk further elevated by early use, heavy use, and genetic vulnerability such as COMT polymorphisms.

Differential Diagnosis

The differential diagnosis includes schizophrenia (requiring 6 months of symptoms, including prodromal and residual phases, with at least 1 month of active-phase symptoms), schizophreniform disorder (schizophrenia-like presentation lasting 1-6 months), brief psychotic disorder (psychotic symptoms lasting less than 1 month, often with a precipitating stressor), schizoaffective disorder (concurrent mood episodes with psychotic symptoms that also occur outside mood episodes), bipolar disorder with psychotic features (psychosis occurring exclusively during mood episodes), MDD with psychotic features (mood-congruent or mood-incongruent psychotic symptoms during depressive episodes), PTSD with dissociative features (flashbacks and dissociative experiences mimicking hallucinations), anti-NMDA receptor encephalitis (young females, psychiatric symptoms followed by seizures, movement disorders, and autonomic instability), and substance-induced psychotic disorder (temporal relationship with substance use).

Coordinated Specialty Care (CSC)

The RAISE Study (Recovery After an Initial Schizophrenia Episode)

The RAISE-ETP (Early Treatment Program) was a landmark NIMH-funded RCT comparing NAVIGATE, a comprehensive CSC program, to community care for FEP. The study enrolled 404 participants ages 15-40 across 34 sites in the United States. NAVIGATE participants showed significantly greater improvement in quality of life, psychopathology, and involvement in work or school compared to those receiving community care. The benefit was greatest for patients with shorter DUP (less than 74 weeks). The results led to widespread dissemination of CSC programs and SAMHSA funding for FEP programs across the country.

Components of CSC

1. Individualized Medication Management

Pharmacotherapy in CSC follows a low-dose, second-generation antipsychotic approach as first-line. The NAVIGATE algorithm recommends starting with aripiprazole or risperidone at low doses, titrating slowly. The guiding principle is "start low, go slow," reflecting the fact that adolescents are more sensitive to side effects, particularly metabolic effects and extrapyramidal symptoms. Typical starting doses for adolescents are aripiprazole 2-5 mg, risperidone 0.5-1 mg, or quetiapine 50-100 mg. Shared decision-making with the patient and family about medication choice is a core element. Metabolic monitoring should follow a structured protocol: weight, BMI, fasting glucose, and lipid panel at baseline, 4, 8, and 12 weeks, then quarterly.

2. Individual Resiliency Training (IRT) / CBT for Psychosis

The individual therapy component is a manualized intervention addressing psychoeducation about psychosis and recovery, cognitive strategies for coping with positive symptoms, behavioral activation and goal setting, stress management and relapse prevention, and substance use reduction. For adolescents, the approach is adapted to use developmentally appropriate language and to focus on identity development, peer relationships, and re-engagement with school.

3. Family Psychoeducation and Support

Family intervention includes education about psychosis, treatment, and prognosis, communication skills training aimed at reducing expressed emotion, problem-solving strategies, and support for family members' own emotional needs. Family involvement is associated with better treatment engagement and lower relapse rates, and it is particularly critical for adolescents who are still living with and dependent on their families.

4. Supported Employment and Education (SEE)

The supported employment and education component follows the Individual Placement and Support (IPS) model adapted for young people. It focuses on returning to school or initiating employment based on patient preferences, using rapid placement with ongoing support rather than prolonged pre-vocational training. For adolescents, this includes academic accommodations, tutoring, and liaison with schools. Engagement in employment or education is associated with better long-term outcomes and recovery.

Other CSC Programs

Other notable CSC programs include OnTrackNY (New York State's FEP program with demonstrated effectiveness), EPINET (NIMH's Early Psychosis Intervention Network for research and quality improvement), NAVIGATE (the specific CSC model tested in RAISE), and STEP (Specialized Treatment Early in Psychosis, a Connecticut-based early psychosis program).

Prognosis and Course

FEP outcomes are heterogeneous: approximately 20% achieve full recovery, 30-40% have an episodic course with good inter-episode functioning, and 30-40% have chronic persistent illness. Better prognostic indicators include acute onset, good premorbid functioning, prominent mood symptoms, female sex, shorter DUP, and family involvement. Worse prognostic indicators include insidious onset, poor premorbid functioning, prominent negative symptoms, male sex, longer DUP, substance use, and childhood onset. For relapse prevention, medication adherence is the strongest modifiable predictor of relapse, with psychoeducation, family support, and substance avoidance also reducing risk.

<image>A diagram showing the components of Coordinated Specialty Care (CSC) for first-episode psychosis. Central hub labeled "FEP Patient and Family." Four spokes radiating out: (1) Low-dose antipsychotic medication management (with shared decision-making), (2) Individual resiliency training / CBT for psychosis, (3) Family psychoeducation and support, (4) Supported employment and education (IPS model). Show the team members involved: psychiatrist, therapist, family clinician, SEE specialist, and team leader. Include RAISE study outcomes: superior quality of life and functioning compared to community care.</image>

<image>A visual illustrating the concept of Duration of Untreated Psychosis (DUP) and its impact on outcomes. Show a timeline from prodromal symptoms to psychosis onset to treatment initiation. Label DUP as the gap between psychosis onset and treatment. Show a graph demonstrating that shorter DUP is associated with better outcomes (quality of life, symptom response, functional recovery) while longer DUP is associated with worse outcomes. Include the statistic: mean DUP in the US is approximately 74 weeks.</image>

<image>A medical workup checklist for first-episode psychosis in adolescents, organized by category. Labs: CBC, CMP, TFTs, urine drug screen, HIV, RPR, ceruloplasmin. Imaging: brain MRI. Special tests: anti-NMDA receptor antibodies (if atypical features), EEG (if seizures suspected), chromosomal microarray (if developmental concerns). Highlight red flags for organic causes: very young age, acute onset with confusion, neurological signs, seizures, movement abnormalities, autonomic instability.</image>

Clinical Pearls

FEP is a psychiatric emergency, and reducing DUP is one of the most impactful interventions for long-term outcomes. A thorough medical workup is mandatory in adolescent FEP because organic causes, especially anti-NMDA receptor encephalitis and substance-induced psychosis, are squarely in the differential. Cannabis use in adolescence significantly increases schizophrenia risk, and a detailed substance history should always be obtained. Low-dose antipsychotics with slow titration is the pharmacological principle for FEP, as adolescents are more sensitive to side effects than adults. CSC programs using the NAVIGATE model produce significantly better outcomes than treatment as usual, and patients should be referred to the nearest CSC program when available. Family involvement is critical for adolescent FEP, and high expressed emotion (criticism, hostility, and over-involvement) increases relapse risk. Engagement in school or work through supported education and employment is a recovery-oriented goal that should be addressed early rather than deferred. Approximately 20-30% of FEP patients will have a good outcome with full functional recovery, and clinicians should avoid communicating an unduly pessimistic prognosis.

References

• Kane, J.M. et al. (2016). Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. American Journal of Psychiatry, 173(4), 362-372.
• Correll, C.U. et al. (2018). Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review and meta-analysis. JAMA Psychiatry, 75(6), 555-565.
• Srihari, V.H. et al. (2015). First-episode services for psychotic disorders in the US public sector. Psychiatric Services, 66(10), 1107-1109.
• McClellan, J. & Stock, S. (2013). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. JAACAP, 52(9), 976-990.
• NAVIGATE Program materials. Available at: navigateconsultants.org
• Large, M. et al. (2008). The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review. Schizophrenia Research, 103(1-3), 121-127.

Read this lecture as Markdown